139232-80-7
Chemical Structure
BMS-188107
- CAS No.: 139232-80-7
- Formula:C25H26N2O4
- Molecular Weight:418.48
IUPAC Name: (3R,4S)-6-benzyl-3-hydroxy-2,2-dimethyl-4-(2-oxopyrrolidin-1-yl)-2,3,4,6-tetrahydro-5H-pyrano[3,2-c]quinolin-5-one
InChIKey: KLSKINYBELQIRV-JTHBVZDNSA-N
SMILES: O=C1N(C2=C(C3=C1[C@@H]([C@H](C(C)(O3)C)O)N4C(CCC4)=O)C=CC=C2)CC5=CC=CC=C5
Biological Activity: BMS-188107 is a calcium antagonist that exerts anti-ischemic effects. BMS-188107 improves postischemic contractile function and reduces lactate dehydrogenase release. BMS-188107 can be utilized in cardiovascular research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BMS-188107 | BMS-188107 is a calcium antagonist that exerts anti-ischemic effects. BMS-188107 improves postischemic contractile function and reduces lactate dehydrogenase release. BMS-188107 can be utilized in cardiovascular research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords